4//SEC Filing
HOLUBOW FRED 4
Accession 0001209191-10-047747
CIK 0001028318other
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 6:10 PM ET
Size
21.0 KB
Accession
0001209191-10-047747
Insider Transaction Report
Form 4
HOLUBOW FRED
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$5.89/sh−10,000$58,900→ 0 totalExercise: $17.51Exp: 2017-11-12→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$22.64/sh−5,444$123,225→ 0 totalExercise: $0.77Exp: 2013-06-24→ Common Stock (5,444 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$10.35/sh−17,777$183,992→ 0 totalExercise: $13.05Exp: 2014-06-24→ Common Stock (17,777 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$9.94/sh−10,000$99,400→ 0 totalExercise: $13.46Exp: 2019-09-15→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$5.72/sh−10,000$57,200→ 0 totalExercise: $17.68Exp: 2016-11-14→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$10.56/sh−10,000$105,600→ 0 totalExercise: $12.84Exp: 2018-09-16→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$17.77/sh−8,888$157,984→ 0 totalExercise: $5.63Exp: 2014-11-15→ Common Stock (8,888 underlying) - Disposition to Issuer
Common Stock
2010-09-27−18,167→ 0 total
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 11, 2010, between Micrus Endovascular Corporation, Johnson & Johnson and Cope Acquisition Corp., each share of common stock held by the reporting person was converted into the right to receive $23.40 in cash, without interest.
- [F2]Pursuant to the Agreement and Plan of Merger, dated as of July 11, 2010, between Micrus Endovascular Corporation, Johnson & Johnson and Cope Acquisition Corp., this stock option was converted into the right to receive an amount in cash per share subject to the stock option equal to the excess of the per share merger consideration of $23.40 over the per share exercise price of such stock option, without interest.
Documents
Issuer
MICRUS ENDOVASCULAR CORP
CIK 0001028318
Entity typeother
Related Parties
1- filerCIK 0000905478
Filing Metadata
- Form type
- 4
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 6:10 PM ET
- Size
- 21.0 KB